Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
BioLife Solutions Stock

BioLife Solutions Stock BLFS

BLFS
US09062W2044
A1XCF2

Price

0
Today +/-
-0
Today %
-0 %

BioLife Solutions stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the BioLife Solutions stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the BioLife Solutions stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the BioLife Solutions stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze BioLife Solutions's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

BioLife Solutions Stock Price History

DateBioLife Solutions Price
8/5/20250 undefined
8/5/202520.52 undefined
8/4/202520.91 undefined
7/31/202520.81 undefined
7/30/202521.26 undefined
7/29/202521.82 undefined
7/28/202522.10 undefined
7/27/202522.23 undefined
7/25/202522.43 undefined
7/24/202522.49 undefined
7/23/202522.33 undefined
7/22/202521.08 undefined
7/21/202520.67 undefined
7/18/202520.97 undefined
7/17/202521.44 undefined
7/16/202521.19 undefined
7/15/202520.98 undefined
7/14/202522.17 undefined
7/11/202521.94 undefined
7/10/202522.87 undefined
7/9/202522.31 undefined
7/8/202522.57 undefined
7/7/202522.04 undefined

BioLife Solutions Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into BioLife Solutions, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by BioLife Solutions from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects BioLife Solutions’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of BioLife Solutions. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into BioLife Solutions’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing BioLife Solutions’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on BioLife Solutions’s growth potential.

BioLife Solutions Revenue, EBIT and net profit per share

DateBioLife Solutions RevenueBioLife Solutions EBITBioLife Solutions Net Income
2030e296.38 M undefined0 undefined0 undefined
2029e231.65 M undefined56.92 M undefined0 undefined
2028e183.12 M undefined38.18 M undefined0 undefined
2027e145.91 M undefined24.93 M undefined23.49 M undefined
2026e117.16 M undefined1.91 M undefined3.01 M undefined
2025e99.71 M undefined-6.71 M undefined-4.54 M undefined
202482.25 M undefined-7.13 M undefined-20.18 M undefined
202375.86 M undefined-23.44 M undefined-68 M undefined
2022161.8 M undefined-35.1 M undefined-139.8 M undefined
2021119.2 M undefined-33.5 M undefined-8.9 M undefined
202048.1 M undefined-5.5 M undefined1.8 M undefined
201927.4 M undefined700,000 undefined-1.7 M undefined
201819.7 M undefined3.7 M undefined-25.3 M undefined
201711 M undefined-1.1 M undefined-2.7 M undefined
20168.2 M undefined-4.9 M undefined-6.9 M undefined
20156.4 M undefined-5 M undefined-4.2 M undefined
20146.2 M undefined-3.1 M undefined-3.2 M undefined
20138.9 M undefined-300,000 undefined-1.1 M undefined
20125.7 M undefined-900,000 undefined-1.7 M undefined
20112.8 M undefined-1.2 M undefined-2 M undefined
20102.1 M undefined-1.4 M undefined-2 M undefined
20091.6 M undefined-1.9 M undefined-2.8 M undefined
20081.3 M undefined-2.2 M undefined-2.8 M undefined
20071 M undefined-2.5 M undefined-2.9 M undefined
2006600,000 undefined-1.5 M undefined-1.1 M undefined
2005600,000 undefined-600,000 undefined-600,000 undefined

BioLife Solutions Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
0000005131363211000000111225866811192748119161758299117145183231296
-------160.00--53.85-50.00-33.33-50.00----------100.00-150.0060.00-25.00-33.3337.5072.7342.1177.78147.9235.29-53.429.3320.7318.1823.9326.2126.2328.14
------20.0046.1553.8550.0033.3350.005,300.005,300.00------5,300.005,300.005,300.002,650.0050.0040.0037.5050.0050.0050.0054.5568.4266.6756.2531.0932.9260.0064.6353.5445.3036.5528.9622.9417.91
000000167311000000000000123334613182737534553000000
000-1-2-4-6-2-2-3-1-1-1-2-40-100-1-2-2-2-2-2-1-1-3-4-6-2-25-11-8-139-68-20-4323000
----100.00100.0050.00-66.67-50.00-66.67--100.00100.00-----100.00-----50.00-200.0033.3350.00-66.671,150.00-96.00-200.00-900.001,637.50-51.08-70.59-80.00-175.00666.67---
0.060.110.10.20.20.30.30.30.40.40.50.50.50.70.90.90.90.90.93.8555555510.412.212.613.316.319.527.338.542.543.7246.07000000
--------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The BioLife Solutions Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the BioLife Solutions is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (k)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (k)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (k)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
1988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                         
0.53.45.412.13.12.51.21.41.90.10.102.20.30.10.80.50.20.10.10.10.1000.20.29.93.81.46.730.76.490.469.919.451.7104.58
00002.633.21.61.410.50.20.10.1000.10.10.10.30.30.30.30.50.610.90.91.2135.3823.233.918.669.17
000000000000000.12000000000000000000000
0000.21.42.12.61.71.71.71.210.70.5000.10.10.10.10.60.40.40.50.70.411.81.81.83.51111.628.334.943.4629.01
0.100.10.20.10.30.30.20.10.10.10.10.1000000.20.100.10.10.10.20.30.40.40.30.40.41.34.74.750.26.86
0.63.45.512.57.27.97.34.95.12.91.91.33.10.90.22.80.70.40.50.610.90.81.11.71.912.26.94.79.937.624114.7126.1138.4120.6148.76
000.10.41.21.21.10.9110.80.50.40.50.20.10.10.100.10.10.40.40.41.31.31.71.41.21.11.310.524.546.648.340.3322.86
00000000000000000000000000002.11.16.52.55.94.45.15.625.62
0000000000000000000000000000000000000
000000000000.40.50.50000000000002.23.90002231152.132.121.159.56
000000000000000000000000000000033.658.4224.7224.7224.74212.3
00000000000000000000000.10.10.20.2000000.10.20.31.60.270.38
000.10.41.21.21.10.9110.80.90.910.20.10.10.100.10.10.40.50.51.51.53.95.33.32.27.868.7120428.1311.8292.11250.73
0.63.45.612.98.49.18.45.86.13.92.72.241.90.42.90.80.50.50.71.11.31.31.63.23.416.112.2812.145.492.7234.7554.2450.2412.71399.49
                                                                         
2000000000000000000010010010010010010010000000000004547
0.76.211.722.92325.326.228.530.530.630.831.336.93838.440.740.740.741.942.142.242.342.642.943.343.671.972.874.484113143.5302.6585.4611.7651.31683.94
-0.8-2.5-6-10.8-17.4-20-22.3-25.7-26.5-28.1-29.4-30.5-33.3-37.7-37.5-39.3-40.1-40.7-41.8-44.7-47.4-50.2-52.2-54.2-55.8-56.9-60.1-64.3-71.2-74-98.4-100.1-97.4-107.1-246.9-313.34-335.1
0-500-300-1000000000000-1,400000000000000000000-300-700-34524
0000000000000000000000000000000000000
0.13.25.4125.65.33.92.842.51.40.83.60.3-0.51.40.600.2-2.5-5.1-7.8-9.5-11.2-12.4-13.311.88.53.21014.643.4205.2478364.1337.66348.91
00.20.10.91.822.41.81.210.60.60.110.20.60.10.10.10.10.70.20.10.40.90.90.510.70.70.73.13.714.915.46.943.57
00000.30.81.10.80.70.30.40.50.20.50.40.30.10.10.10.30.20.10.20.20.40.60.70.60.30.71.14.24.911.416.219.5118.12
00000.10.10.10000.100000000000000.10.10.10.10.10.10.10.46.315.3118.520.1
50000000000010010000300700000000000000000000000
0000000000000000000.200000000000000.6127.2110.94
0.50.20.10.92.22.93.62.61.91.31.21.20.31.50.91.60.20.20.40.40.90.30.30.61.41.61.31.71.11.51.97.715.542.644.642.1832.73
0000000000.10.10000000.202.85.17.9910.110.610.6002.80000.76.623.919.485
0000000000000000000000000000000005.50.30.190.12
00000.510.90.40.2000000000000.40.91.52.13.74.40.90.80.80.528.941.713.321.417.313.2112.72
00000.510.90.40.20.10.10000000.202.85.58.810.512.214.3150.90.83.60.528.941.71433.541.532.8717.84
0.50.20.10.92.73.94.532.11.41.31.20.31.50.91.60.20.40.43.26.49.110.812.815.716.62.22.54.7230.849.429.576.186.175.0550.58
0.63.45.512.98.39.28.45.86.13.92.723.91.80.430.80.40.60.71.31.31.31.63.33.314117.91245.492.8234.7554.1450.2412.71399.49
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of BioLife Solutions provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand BioLife Solutions's financial health and stability.

Assets

BioLife Solutions's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that BioLife Solutions must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of BioLife Solutions after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into BioLife Solutions's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (k)
NON-CASH ITEM (M)
PAID INTEREST (k)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
1988198919901991199219931994199519961996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
00-1-2-4-6-2-2-30-1-1-1-2-40-100-1-2-2-2-1-1-1-1-3-5-8-23-11-8-139-66
0000000000000000000000000000000015121612
00000000000000000000000000000000-1-3-20-50
00000-2,000001,0000001,000000-1,0001,00000000001,00000000-3,000-4,000-1,000-2,000-14,0001,000
000000000000001-210000000010004331092716071
0000000000000000000000000000000000001,000
0000000000000000000000000000000000000
00-1-2-4-8-2-1-2-1-100-2-2-20000-2-2-2-1000-3-4-40216-4-8-12
0000000000000000000000000-100-1-100-2-7-14-13-11
00-10-970000000002000000000-10-8400-6-27-24-13-5817
00-10-98100000000200000000000-7510-6-24-161-4429
0000000000000000000000000000000000000
11500000110005000000222110013030000-2170
00-1711020000000101000000000000031211011010
114411020210005101000222110013034281102-21610
000-20000000000000000000000000001500-1-10
0000000000000000000000000000000000000
0012-200-100-1002-1000000000000200524-2484-20-5015
-0.58-0.58-1.36-2.54-4.69-9.32-2.86-1.86-2.1-1.4-1.86-0.22-0.49-3.1-2.92-2.77-0.860.45-0.6-0.75-2.82-2.16-2.78-1.28-1.08-0.3-0.09-3.75-6.39-5.590.471.85-1.12-1.16-19.35-22.41-23.74
0000000000000000000000000000000000000

BioLife Solutions stock margins

The BioLife Solutions margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioLife Solutions. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioLife Solutions.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the BioLife Solutions's sales revenue. A higher gross margin percentage indicates that the BioLife Solutions retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the BioLife Solutions's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the BioLife Solutions's total revenue generated. When comparing the revenue margin year over year, investors can gauge the BioLife Solutions's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the BioLife Solutions. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the BioLife Solutions's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

BioLife Solutions Margin History

BioLife Solutions Gross marginBioLife Solutions Profit marginBioLife Solutions EBIT marginBioLife Solutions Profit margin
2030e65.25 %0 %0 %
2029e65.25 %24.57 %0 %
2028e65.25 %20.85 %0 %
2027e65.25 %17.09 %16.1 %
2026e65.25 %1.63 %2.57 %
2025e65.25 %-6.73 %-4.56 %
202465.25 %-8.67 %-24.54 %
202360.55 %-30.9 %-89.65 %
202233.25 %-21.69 %-86.4 %
202131.04 %-28.1 %-7.47 %
202056.96 %-11.43 %3.74 %
201967.88 %2.55 %-6.2 %
201868.53 %18.78 %-128.43 %
201760.91 %-10 %-24.55 %
201658.54 %-59.76 %-84.15 %
201559.38 %-78.13 %-65.62 %
201448.39 %-50 %-51.61 %
201342.7 %-3.37 %-12.36 %
201240.35 %-15.79 %-29.82 %
201150 %-42.86 %-71.43 %
201042.86 %-66.67 %-95.24 %
200937.5 %-118.75 %-175 %
200846.15 %-169.23 %-215.38 %
200750 %-250 %-290 %
200650 %-250 %-183.33 %
200566.67 %-100 %-100 %

BioLife Solutions Stock Sales Revenue, EBIT, Earnings per Share

The BioLife Solutions earnings per share therefore indicates how much revenue BioLife Solutions has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue BioLife Solutions earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates BioLife Solutions's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of BioLife Solutions’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating BioLife Solutions's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

BioLife Solutions Revenue, EBIT and net profit per share

DateBioLife Solutions Sales per ShareBioLife Solutions EBIT per shareBioLife Solutions Earnings per Share
2030e6.43 undefined0 undefined0 undefined
2029e5.03 undefined0 undefined0 undefined
2028e3.98 undefined0 undefined0 undefined
2027e3.17 undefined0 undefined0.51 undefined
2026e2.54 undefined0 undefined0.07 undefined
2025e2.16 undefined0 undefined-0.1 undefined
20241.79 undefined-0.15 undefined-0.44 undefined
20231.74 undefined-0.54 undefined-1.56 undefined
20223.81 undefined-0.83 undefined-3.29 undefined
20213.1 undefined-0.87 undefined-0.23 undefined
20201.76 undefined-0.2 undefined0.07 undefined
20191.41 undefined0.04 undefined-0.09 undefined
20181.21 undefined0.23 undefined-1.55 undefined
20170.83 undefined-0.08 undefined-0.2 undefined
20160.65 undefined-0.39 undefined-0.55 undefined
20150.52 undefined-0.41 undefined-0.34 undefined
20140.6 undefined-0.3 undefined-0.31 undefined
20131.78 undefined-0.06 undefined-0.22 undefined
20121.14 undefined-0.18 undefined-0.34 undefined
20110.56 undefined-0.24 undefined-0.4 undefined
20100.42 undefined-0.28 undefined-0.4 undefined
20090.32 undefined-0.38 undefined-0.56 undefined
20080.26 undefined-0.44 undefined-0.56 undefined
20070.2 undefined-0.5 undefined-0.58 undefined
20060.16 undefined-0.39 undefined-0.29 undefined
20050.67 undefined-0.67 undefined-0.67 undefined

BioLife Solutions business model

BioLife Solutions Inc. was founded in 1998 and has since been continuously working on the development and production of bioproducts. The company is based in Bothell, Washington and employs over 50 staff members. BioLife Solutions specializes in the development of biological storage and transportation solutions, offering innovative products and services to companies in the biotechnology, cell therapy, and regenerative medicine sectors. The business model of BioLife Solutions is based on the sale of cryopreservation media and devices for packaging and storing biological materials. The company offers a wide range of products and services, including bioproducts, cryopreservation media, cell transport containers, and automatic freezers. These products allow companies in the biotechnology, cell therapy, and regenerative medicine industries to safely and effectively transport and store their products, contributing to increased product quality. BioLife Solutions works with leading biotechnology companies, cell therapy centers, and scientific institutions. The company has a strong network in the industry and is able to offer customized solutions to meet specific customer requirements. BioLife Solutions prides itself on not only providing biological products and devices to its customers but also offering expert advice and support in product selection and service. BioLife Solutions offers various divisions, such as cryopreservation media, cell transport containers, and automatic freezers. The cryopreservation media are typically mixed with cells before being frozen and stored. The special media ensure that the cells maintain their biological properties during storage and can be reactivated when needed. BioLife Solutions' cell transport containers are designed to safely transport cells without damage. These containers are available in different sizes and shapes and ensure the safe transport of cells and tissues worldwide. BioLife Solutions' automatic freezers are equipped with an intelligent system that automates the storage and management of biological materials. The products are designed to meet specific customer requirements and contribute to increased product quality. In terms of products, BioLife Solutions offers a wide range of innovative solutions. One of its most well-known products is CryoStor, a cryopreservation media frequently used in cell storage and transport. CryoStor allows companies to store and transport their cells safely and effectively. BioLife Solutions has also developed an automatic cell storage device called SmartStore, which is capable of automatically storing and monitoring biological materials. SmartStore provides an intelligent and user-friendly solution for the automatic storage of biological materials and contributes to improved product quality. BioLife Solutions' mission is to offer innovative biological products and solutions that contribute to improved product quality and simplified biological research and therapy. The company continues to strive for the development of products that meet specific customer requirements and help improve the biotechnology industry. BioLife Solutions is one of the most popular companies on Eulerpool.com.

BioLife Solutions SWOT Analysis

Strengths

1. Strong product portfolio: BioLife Solutions Inc offers a diverse range of innovative biopreservation tools and services, which cater to the growing needs of the biotech and pharmaceutical industries.

2. Established reputation: The company has built a solid reputation for delivering high-quality, reliable products, ensuring customer satisfaction and loyalty.

3. Robust research and development: BioLife Solutions Inc invests heavily in R&D, allowing them to stay at the forefront of technological advancements and develop cutting-edge solutions for their customers.

Weaknesses

1. Dependence on a few key customers: The company relies heavily on a small number of customers for a significant portion of its revenue, making it vulnerable to any changes in their preferences or buying patterns.

2. Limited global presence: BioLife Solutions Inc primarily operates in North America, which restricts its market reach and potential growth opportunities in other geographical regions.

3. Relatively small market share: Despite being a leader in biopreservation solutions, the company faces intense competition from larger, more established players in the industry.

Opportunities

1. Growing biotech and pharmaceutical sectors: The increasing demand for biopreservation tools and services presents immense growth opportunities for BioLife Solutions Inc.

2. Expansion into international markets: Exploring and expanding operations in new geographical regions would help the company tap into untapped markets and increase its customer base.

3. Strategic partnerships and collaborations: Forming partnerships with other industry players or research institutions could enhance BioLife Solutions Inc's capabilities and open doors to new technologies and markets.

Threats

1. Competitive market landscape: The biopreservation industry is highly competitive, with numerous established and emerging players vying for market share, which could potentially impact BioLife Solutions Inc's growth and profitability.

2. Regulatory challenges: Changes in government regulations pertaining to biopreservation or concerns related to product safety can pose challenges and increase compliance costs for the company.

3. Economic uncertainties: Global economic fluctuations or downturns may affect the spending capacity of BioLife Solutions Inc's customers, potentially impacting their demand for biopreservation products and services.

BioLife Solutions Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

BioLife Solutions Revenue by Segment

Segmente20192018
Product26.84 M USD-
Biopreservation Media23.36 M USD-
Regenerative Medicine-11.03 M USD
Distribution Service-6.42 M USD
Freezers and Accessories2.14 M USD-
Drug Discovery-1.2 M USD
Automated Thawing Products1.18 M USD-
BioBanking-1.1 M USD
Evo Shippers692,000 USD-
Rental Revenue527,000 USD-
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

BioLife Solutions Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

BioLife Solutions historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

BioLife Solutions shares outstanding

The number of shares was BioLife Solutions in 2024 — This indicates how many shares 46.067 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue BioLife Solutions earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates BioLife Solutions's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of BioLife Solutions’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating BioLife Solutions's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

BioLife Solutions stock splits

In BioLife Solutions's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for BioLife Solutions.

BioLife Solutions latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/2025-0.05 -0.01  (81.45 %)2025 Q1
12/31/2024-0.07 0.26  (496.34 %)2024 Q4
9/30/2024-0.09 -0.04  (55.01 %)2024 Q3
6/30/2024-0.14 -0.5  (-246.5 %)2024 Q2
3/31/2024-0.29 -0.23  (19.47 %)2024 Q1
12/31/2023-0.35 -0.3  (13.92 %)2023 Q4
9/30/2023-0.38 -0.3  (21.57 %)2023 Q3
6/30/2023-0.2 -0.23  (-12.75 %)2023 Q2
3/31/2023-0.22 -0.32  (-48.35 %)2023 Q1
12/31/2022-0.17 -1.15  (-576.47 %)2022 Q4
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the BioLife Solutions stock

Eulerpool World ESG Rating (EESG©)

23/ 100

🌱 Environment

24

👫 Social

35

🏛️ Governance

10

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

BioLife Solutions shareholders

%
Name
Stocks
Change
Date
18.96182 % Casdin Capital, LLC8,735,15927,9944/7/2025
11.00483 % BlackRock Institutional Trust Company, N.A.5,069,606-141,2623/31/2025
7.22836 % Invesco Advisers, Inc.3,329,894274,5533/31/2025
6.06912 % The Vanguard Group, Inc.2,795,867-32,1173/31/2025
3.32802 % Fred Alger Management, LLC1,533,122-61,0993/31/2025
3.11241 % State Street Global Advisors (US)1,433,796-35,2823/31/2025
2.92618 % T. Rowe Price Investment Management, Inc.1,348,0081,348,0083/31/2025
2.09316 % Rockefeller Capital Management964,257142,4933/31/2025
2.05588 % Palisade Capital Management, LLC947,085113,9373/31/2025
2.05488 % William Blair Investment Management, LLC946,62336,2753/31/2025
1
2
3
4
5
...
10

BioLife Solutions Executives and Management Board

Mr. Roderick De Greef

(63)
BioLife Solutions Chairman of the Board, Chief Executive Officer (since 2000)
Compensation 5.6 M

Mr. Troy Wichterman

(39)
BioLife Solutions Chief Financial Officer
Compensation 1.7 M

Dr. Aby Mathew

(52)
BioLife Solutions Chief Scientific Officer, Executive Vice President
Compensation 1.35 M

Mr. Geraint Phillips

(58)
BioLife Solutions Senior Vice President - Global Operations
Compensation 1.3 M

Ms. Karen Foster

(64)
BioLife Solutions Chief Quality and Operations Officer
Compensation 1.12 M
1
2
3

BioLife Solutions Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Thermo Fisher Scientific Stock
Thermo Fisher Scientific
SupplierCustomer0,770,860,480,820,120,31
Avantor Stock
Avantor
SupplierCustomer0,720,740,850,970,790,57
Catalent Stock
Catalent
SupplierCustomer0,660,310,660,820,820,77
Twinbird Stock
Twinbird
SupplierCustomer0,630,260,720,860,810,43
Merck Stock
Merck
SupplierCustomer-0,080,410,580,880,370,39
1

Most common questions regarding BioLife Solutions

What values and corporate philosophy does BioLife Solutions represent?

BioLife Solutions Inc is a leading provider of biopreservation tools and services. The company's values center around innovation, quality, and customer satisfaction. With a strong commitment to advancing regenerative medicine and improving patient outcomes, BioLife Solutions Inc focuses on delivering best-in-class biopreservation solutions to its clients. The corporate philosophy of the company revolves around continuous improvement and collaboration with customers, researchers, and industry partners. By offering a wide range of high-performance biopreservation products and leveraging its expertise in cell and tissue preservation, BioLife Solutions Inc strives to contribute to the success and progress of the life sciences industry.

In which countries and regions is BioLife Solutions primarily present?

BioLife Solutions Inc is primarily present in the United States. With its headquarters located in Bothell, Washington, the company operates throughout the country. As a leading provider of biopreservation tools and services, BioLife Solutions Inc serves a diverse customer base in the life sciences industry across various states and regions in the United States. The company focuses on supplying innovative bioprocessing solutions and ensuring the quality and preservation of biological materials, such as cells, tissues, and organs, for medical research and therapeutic purposes.

What significant milestones has the company BioLife Solutions achieved?

BioLife Solutions Inc. has accomplished several significant milestones. The company has expanded its product portfolio, offering a comprehensive range of innovative biopreservation solutions for cells, tissues, and organs. It has successfully developed and commercialized proprietary technologies to enhance the shelf life and improve the efficacy of biological materials. Furthermore, BioLife Solutions has achieved consistent revenue growth and profitability, demonstrating its strong market presence and customer satisfaction. The company has also forged strategic partnerships with leading organizations, leveraging its expertise to develop cutting-edge biopreservation systems. These achievements highlight BioLife Solutions Inc.'s commitment to advancing biological storage and transportation solutions while delivering value to its customers and stakeholders.

What is the history and background of the company BioLife Solutions?

BioLife Solutions Inc, a leading developer and supplier of biopreservation tools for cells and tissues, has a rich history and background. Founded in 1998, the company has been dedicated to improving the quality and extending the shelf life of biological materials. BioLife Solutions Inc specializes in innovative solutions that enable the effective storage, freezing, and transportation of biological samples used in research, clinical trials, and regenerative medicine. With a strong focus on quality and customer satisfaction, BioLife Solutions Inc has become a trusted partner for biotech and pharmaceutical companies worldwide. The company's commitment to continuous innovation and collaboration underscores its position as a leader in the biopreservation industry.

Who are the main competitors of BioLife Solutions in the market?

The main competitors of BioLife Solutions Inc in the market include companies such as Thermo Fisher Scientific Inc, Merck KGaA, Teva Pharmaceutical Industries Ltd, and Zimmer Biomet Holdings Inc.

In which industries is BioLife Solutions primarily active?

BioLife Solutions Inc is primarily active in the biotechnology industry.

What is the business model of BioLife Solutions?

BioLife Solutions Inc is a biotech company specializing in developing, manufacturing, and marketing cell and tissue preservation solutions. Their business model revolves around providing innovative products that enhance the effectiveness of biological materials storage and transportation. BioLife Solutions offers a comprehensive portfolio of biopreservation media, enabling improved cell therapies, vaccines, and drug discovery research. By supplying high-quality, proprietary products, BioLife Solutions caters to the needs of various sectors, including regenerative medicine, biobanking, and pharmaceuticals. Through their advanced technologies and solutions, BioLife Solutions Inc aims to support the success of customers in preserving and delivering vital biological materials.

What is the P/E ratio of BioLife Solutions 2025?

The P/E ratio cannot be calculated for BioLife Solutions at the moment.

What is the P/S ratio of BioLife Solutions 2025?

The P/S cannot be calculated for BioLife Solutions currently.

What is the Quality Investing of BioLife Solutions?

The Quality Investing for BioLife Solutions is 3/10.

What is the revenue of BioLife Solutions 2025?

The expected BioLife Solutions revenue is 99.71 M USD.

How high is the profit of BioLife Solutions 2025?

The expected BioLife Solutions profit is -4.54 M USD.

What is the business model of BioLife Solutions

BioLife Solutions Inc is a company specializing in the production of high-quality biological solutions for customers in the biopharmaceutical and biotechnology industries. The business is divided into two main divisions: BioLife Solutions and Astero Bio. BioLife Solutions focuses on manufacturing proprietary biological solutions for customers in the biopharmaceutical and biotechnology industries, which are used for the stabilization and maintenance of the quality of biological materials such as cells, tissues, and organs. Products include CryoStor, a clinically tested cell cryopreservation solution, and HypoThermosol, a patented cell culture medium specifically designed for the storage and transportation of cell and tissue samples. BioLife Solutions also offers custom formulations for specific applications. The second division, Astero Bio, specializes in the development and manufacturing of temperature control devices for biological storage. The Astero portfolio includes cryogenic storage systems that maintain the quality and integrity of biological samples during storage. Astero Bio also offers biological safety cabinets for laboratories handling pathogenic or toxin-producing organisms. BioLife Solutions and Astero Bio work together to provide their customers with a complete solution for the stabilization and protection of biological materials. The products and solutions of BioLife Solutions and Astero Bio are tailored to meet customer requirements and comply with international standards such as Good Manufacturing Practice (GMP) and the International Organization for Standardization (ISO). BioLife Solutions' business model is based on a value chain, starting with the research and development of new biological solutions and extending to the production and market introduction of these solutions. The solutions and products of BioLife Solutions and Astero Bio are designed to meet customer needs and aim to enhance the efficiency and profitability of companies in the biopharmaceutical and biotechnology industries. BioLife Solutions and Astero Bio have a strong position in the global market for biological solutions, and their products are used by leading companies and institutions worldwide. The company has a strong track record and is committed to further growth and expanding its technological capabilities in the future. The products and solutions of BioLife Solutions and Astero Bio contribute to the progress and development in biotechnology, ultimately improving the quality of life for patients worldwide.

What is the BioLife Solutions dividend?

BioLife Solutions pays a dividend of 0 USD distributed over payouts per year.

How often does BioLife Solutions pay dividends?

The dividend cannot currently be calculated for BioLife Solutions or the company does not pay out a dividend.

What is the BioLife Solutions ISIN?

The ISIN of BioLife Solutions is US09062W2044.

What is the BioLife Solutions WKN?

The WKN of BioLife Solutions is A1XCF2.

What is the BioLife Solutions ticker?

The ticker of BioLife Solutions is BLFS.

How much dividend does BioLife Solutions pay?

Over the past 12 months, BioLife Solutions paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioLife Solutions is expected to pay a dividend of 0 USD.

What is the dividend yield of BioLife Solutions?

The current dividend yield of BioLife Solutions is .

When does BioLife Solutions pay dividends?

BioLife Solutions pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioLife Solutions?

BioLife Solutions paid dividends every year for the past 0 years.

What is the dividend of BioLife Solutions?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioLife Solutions located?

BioLife Solutions is assigned to the 'Health' sector.

Wann musste ich die Aktien von BioLife Solutions kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioLife Solutions from 8/5/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/5/2025.

When did BioLife Solutions pay the last dividend?

The last dividend was paid out on 8/5/2025.

What was the dividend of BioLife Solutions in the year 2024?

In the year 2024, BioLife Solutions distributed 0 USD as dividends.

In which currency does BioLife Solutions pay out the dividend?

The dividends of BioLife Solutions are distributed in USD.

All fundamentals about BioLife Solutions

Our stock analysis for BioLife Solutions Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioLife Solutions Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.